April 15, 2026- Artificial Intelligence (AI) technology is transforming the healthcare industry rapidly – and the advent of AI chatbots such as ChatGPT, Claude, Copilot, Gemini and Grok are significantly changing the way providers deliver care and patients seek medical advice.
Many users – both providers and the people they serve – now rely on AI chatbots for answers to common health questions. In fact, more than 40 million people turn to ChatGPT daily for health information, according to a recent analysis from OpenAI.
Family members may use chatbots to check on their own symptoms or their families’ symptoms, while physicians may use these tools for help writing a report or for more information on general medical questions.
Indeed, a growing majority of physicians report using AI tools in practice. Surveys show that about two-thirds (66%) of U.S. physicians now use AI tools at least weekly or daily for tasks ranging from documentation to clinical support, and adoption of AI has doubled in a single year, from around 38% to 66% in 2024.
Despite how reliable and truthful chatbots may seem to the user, when it comes to medical purposes, chatbots are not considered medical devices – and they’re not approved for medical use by the Food and Drug Administration (FDA). When these tools are used by physicians and their patients incorrectly, chatbots can produce false or misleading health information.
Continue Reading in the latest issue of Repertoire Magazine.
